Industry: Biomedicine Region: US Transaction Price: USD 1 million Transaction Method: Equity Investment
Project introduction:
A 65-year-old American company is in the international leading position in developing, manufacturing and selling all kinds of new products for life science research and clinical diagnosis market, providing life science research, clinical diagnosis, digital biology and other services.
ABO blood type identification, Rh phenotype and Kell test can be carried out on TANGO optimo system by using reagents, reagent red blood cells and microplate.
Microplate can be used for blood group analysis on TANGO optimo system coated with dry monoclonal antiserum, and can be used as a diagnostic product.
ERY is a compact board for manual and automatic sample distribution, which is especially economical for processing s mall and large series of samples. Various configurations for determining ABO, Rhesus factor D, Rhesus formula and Kell ensure excellent flexibility.
Erytype S adhesive tape plate is used for fully automatic treatment by TANGO optimo fully automatic blood type analyzer. Various Erytype S configurations can be combined to produce different test schemes.
Test red blood cells of reverse Biotestcel-A1, -A2, -B, -O and Erytypecell-A1, -A2, -B, -O ha ve been well adjusted, and can be used in tube test or Erytype and Erytype S ..
Advantages of the project:
1. Rich product types to meet various application scenarios and requirements;
2. It has a complete product system of life science research, clinical diagnosis and digital biology.
Cooperation mode:
Cooperate in the form of technical service agreement.